RJA
TMO icon

Raymond James & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Raymond James & Associates’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$363M Buy
586,785
+46,744
+9% +$27.7M 0.22% 81
2024
Q2 		$299M Buy
540,041
+26,475
+5% +$15.2M 0.2% 90
2024
Q1 		$298M Buy
513,566
+43,660
+9% +$24.5M 0.2% 86
2023
Q4 		$249M Buy
469,906
+3,962
+0.9% +$1.92M 0.19% 97
2023
Q3 		$236M Buy
465,944
+16,784
+4% +$8.94M 0.2% 91
2023
Q2 		$234M Buy
449,160
+10,399
+2% +$5.61M 0.19% 91
2023
Q1 		$253M Buy
438,761
+11,499
+3% +$6.48M 0.22% 85
2022
Q4 		$235M Buy
427,262
+26,674
+7% +$14.1M 0.22% 87
2022
Q3 		$203M Buy
400,588
+8,070
+2% +$4.52M 0.21% 97
2022
Q2 		$213M Sell
392,518
-6,628
-2% -$3.65M 0.21% 92
2022
Q1 		$236M Buy
399,146
+40,503
+11% +$23.3M 0.2% 95
2021
Q4 		$239M Buy
358,643
+8,456
+2% +$5.28M 0.19% 93
2021
Q3 		$200M Buy
350,187
+12,462
+4% +$6.84M 0.18% 100
2021
Q2 		$170M Sell
337,725
-2,957
-0.9% -$1.4M 0.16% 123
2021
Q1 		$155M Sell
340,682
-25,207
-7% -$12M 0.16% 125
2020
Q4 		$170M Buy
365,889
+19,377
+6% +$9.09M 0.19% 100
2020
Q3 		$153M Buy
346,512
+12,542
+4% +$5.18M 0.19% 90
2020
Q2 		$121M Buy
333,970
+12,205
+4% +$4.09M 0.16% 114
2020
Q1 		$91.3M Buy
321,765
+7,571
+2% +$2.39M 0.14% 121
2019
Q4 		$102M Sell
314,194
-3,962
-1% -$1.2M 0.13% 140
2019
Q3 		$92.7M Sell
318,156
-243
-0.1% -$69.6K 0.13% 144
2019
Q2 		$93.5M Buy
318,399
+19,436
+7% +$5.35M 0.13% 134
2019
Q1 		$81.8M Buy
298,963
+21,994
+8% +$5.47M 0.12% 152
2018
Q4 		$62M Buy
276,969
+3,628
+1% +$851K 0.11% 174
2018
Q3 		$66.7M Buy
273,341
+26,382
+11% +$6.07M 0.1% 189
2018
Q2 		$51.2M Buy
246,959
+30,033
+14% +$6.37M 0.09% 219
2018
Q1 		$44.8M Buy
216,926
+17,427
+9% +$3.66M 0.08% 228
2017
Q4 		$37.9M Buy
199,499
+12,439
+7% +$2.38M 0.07% 262
2017
Q3 		$35.4M Buy
187,060
+12,925
+7% +$2.34M 0.07% 261
2017
Q2 		$30.4M Sell
174,135
-126
-0.1% -$21.2K 0.07% 282
2017
Q1 		$26.8M Buy
174,261
+43,311
+33% +$6.62M 0.06% 297
2016
Q4 		$18.5M Buy
130,950
+16,455
+14% +$2.43M 0.05% 399
2016
Q3 		$18.2M Buy
114,495
+19,537
+21% +$3.01M 0.05% 369
2016
Q2 		$14M Buy
94,958
+5,134
+6% +$758K 0.04% 425
2016
Q1 		$12.7M Buy
89,824
+7,857
+10% +$1.05M 0.04% 439
2015
Q4 		$11.6M Buy
81,967
+5,132
+7% +$684K 0.04% 473
2015
Q3 		$9.4M Buy
76,835
+12,282
+19% +$1.6M 0.04% 505
2015
Q2 		$8.38M Buy
64,553
+4,298
+7% +$560K 0.03% 584
2015
Q1 		$8.1M Buy
60,255
+4,580
+8% +$590K 0.04% 533
2014
Q4 		$6.98M Buy
55,675
+9,711
+21% +$1.18M 0.03% 537
2014
Q3 		$5.59M Buy
45,964
+1,359
+3% +$165K 0.03% 577
2014
Q2 		$5.26M Buy
44,605
+13,187
+42% +$1.55M 0.03% 611
2014
Q1 		$3.78M Buy
31,418
+5,300
+20% +$630K 0.03% 695
2013
Q4 		$2.91M Buy
26,118
+5,118
+24% +$509K 0.02% 766
2013
Q3 		$1.94M Sell
21,000
-34,534
-62% -$3.12M 0.02% 901
2013
Q2 		$4.7M Buy
+55,534
New +$4.62M 0.04% 453

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Raymond James & Associates's TMO Position: Q3 2024 in Review

Raymond James & Associates increased its Thermo Fisher Scientific (TMO) stake by 8.7% in Q3 2024, buying an estimated $27.7M and bringing the position to 586,785 shares worth $363M. The position accounts for 0.22% of the portfolio, ranked #81.

Raymond James & Associates first reported a position in TMO in Q2 2013 and has held it in 46 quarters since. 2,568 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

  • Raymond James & Associates held 586,785 shares of Thermo Fisher Scientific worth $363M as of Q3 2024.
  • Raymond James & Associates bought 46,744 Thermo Fisher Scientific shares in Q3 2024, an estimated $27.7M.
  • Thermo Fisher Scientific made up 0.22% of Raymond James & Associates's portfolio in Q3 2024, its #81 holding.
  • Raymond James & Associates first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 46 quarters since.
  • 2,568 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.